BIIB Biogen Earnings and EPS analysis

EPS in 2025 (TTM): $10.16

Last Report Period Date: Mar 31, 2025

As of July this year, based on Biogen's most recent financial report, the company's trailing twelve months EPS is $10.16. During 2024, BIIB reported a per-share earnings of $11.21, which shows a rise compared to the EPS of $8.02 recorded in 2023. Biogen's EPS for the quarterly period ending on Mar 31, 2025 came in at $1.65.

The yearly earnings per share during 2024 was $11.21, a rise of 39.8% compared to $8.02 recorded in 2023. Over the quarter ending Mar 31, 2025, the earnings per share came in at $1.65, reflecting a 39.1% decline compared to the same quarter a year earlier. As of March 2025, the TTM EPS is $10.16. During 2023, the annual earnings per share was $8.02, representing a decrease of 61.7% compared to 2022.

Over the past 12 months, Biogen has recorded an earnings per share growth rate of -39.1% (YoY, quarterly). Over an extended period, the company recorded an average EPS annual growth rate of 2.4% per year for the last 3 years. In the last five years, the company had an average annual EPS growth of -18.7%. A ten-year view shows that BIIB has seen an average earnings per share growth of -1% per year.